Has Rajachendra Tumma, MD received payments from drug or device companies?

Yes. Drug and device makers reported $534 in general payments to Rajachendra Tumma, MD across 27 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rajachendra Tumma, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rajachendra Tumma, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rajachendra Tumma, MD

Internal Medicine · Jeanerette, LANPI 1043657455

Payments from drug & device makers

$534in general payments, 2019–2025

Across 27 payments — averaging $19.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$94
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$86
Pfizer$75
Merck$61
Mallinckrodt Hospital Products Inc.$53
Johnson & Johnson$51
plus $114 from 5 others

What the payments were for

Food & beverage$534100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	5	$94
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$86
Pfizer	4	$75
Merck	3	$61
Mallinckrodt Hospital Products Inc.	2	$53
Johnson & Johnson	3	$51
Portola Pharmaceuticals, LLC	1	$33
Smith+Nephew	2	$30
AstraZeneca	1	$20
Inari Medical, Inc.	1	$20
Daxor Corporation	1	$11

How this compares

$534 in reported general payments places this provider in the 55th percentile of 1,528 internal medicine providers in Louisiana.

See all internal medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024

$122,160

Medicare patients

293

Services billed

1,088

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pantoprazole Sodium	38	$177
Amlodipine Besylate	35	$158
Doxycycline Hyclate	16	$149
Hydralazine Hcl	16	$126
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	11	$106
Levofloxacin	28	$102
Carvedilol	24	$93
Atorvastatin Calcium	17	$92
Spironolactone	14	$44
Metoprolol Succinate	15	$36
Prednisone	13	$32
Furosemide	12	$30

Paid to pharmacies, not to this prescriber.

Other internal medicine in Jeanerette

William SmithNew Orleans$50.5M
Robert JeanfreauMetairie$13.4M
Katherine PearceBaton Rouge$12M
Ernest ThompsonBaker$2.1M
Brian LewisNew Orleans$2M
Otis BarnumNatchitoches$1.8M
Satinder SainiCrowley$1.8M
Randall MillerEunice$1.2M
Donna RyanBaton Rouge$991K
Steven DeitelzweigNew Orleans$939K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →